Megan Ji practices general corporate and securities law and represents public and emerging growth companies in a broad range of industries. She has experience with Securities and Exchange Commission periodic reporting and disclosure obligations, IPOs and other public offerings, private financings and general counseling.

Download full bio 


  • AN2 Therapeutics – $79 Million IPO 

  • Rani Therapeutics – $73 Million IPO 

  • Dynavax Technologies – $200 Million Convertible Notes Offering 


  • Columbia Law School
    JD, James Kent Scholar, Harlan Fiske Stone Scholar, 2018

  • Dartmouth College
    AB, Economics, East Asian Studies
    cum laude, 2012

Admissions & Credentials

New York


Media & Insight